Trial NCT04790786

View at ClinicalTrials.gov 
Org. Study IDs: STUDY21020179

Last trial update was posted on 2023-06-15

MeSH Interventions

Bamlanivimab Casirivimab and imdevimab drug combination Sotrovimab

MeSH Conditions

COVID-19

Other Conditions

Covid19

Stopping Reasons

Emergency Use Authorizations for monoclonal antibodies withdrawn

Limitations And Caveats

Results are presented before any prespecified statistical trigger was reached. Lack of patient-level variant data limited ability to assess comparative effectiveness relative to variant strains. The EHR eligibility screen identified most, but not all, EUA risk factors and could not identify if a patient was asymptomatic or severely ill. Finally, vaccination status was unable to be ascertained for this cohort which may impact effectiveness of monoclonal antibody therapy.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID